trending Market Intelligence /marketintelligence/en/news-insights/trending/h9ciizoVsZK1mJPSnOOriQ2 content esgSubNav
In This List

Express Scripts Holding reveals 2018 earnings guidance, boosts 2017 EPS forecast

Video

S&P Capital IQ Pro | Unrivaled Sector Coverage

Video

S&P Capital IQ Pro | Powering Your Edge

Blog

Enterprises are missing out on 24B by not optimizing cloud spending not going multicloud

Blog

Investment Research Analysts Providing Greater Coverage on Inflation


Express Scripts Holding reveals 2018 earnings guidance, boosts 2017 EPS forecast

Express Scripts Holding Co. said it expects adjusted EPS of $7.67 to $7.87 from its consolidated business in 2018.

The S&P Capital IQ consensus normalized EPS estimate for 2018 is $7.75.

The pharmacy benefit manager forecast 2018 revenue of between $99 billion to $102 billion.

Adjusted EBITDA for 2018 is expected to be between $7.6 billion and $7.8 billion.

Express Scripts said its restructuring effort, dubbed an enterprise value initiative, is estimated to cost about $600 million to $650 million and will deliver cumulative savings of nearly $1.2 billion by 2021.

The company's 2018 full-year guidance includes an estimated contribution of $65 million to $75 million in expense savings affecting the core and consolidated businesses.

For 2017, the U.S.-based company raised its forecast for adjusted EPS to $7.00 to $7.08 from the $6.97 to $7.05 range announced earlier this year.

The S&P Capital IQ consensus normalized EPS estimate for 2017 is $7.01.

The company, however, narrowed its 2017 adjusted EBITDA guidance to a range of $7.37 billion to $7.45 billion from $7.35 billion to $7.47 billion.